Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

BIZARRE: 15 - What They Never Told You

New Covid vaccines targeting KP.2 variant approved; 5 things to know

As the summer wave, dominated by FlirT variants, takes over the United States, The Food and Drug Administration has approved updated Covid-19 vaccines that specifically target recent variant of the disease - KP.2.

The Times of India

Updated COVID mRNA Vaccines Get FDA Approval: Here's What To Know

Updated COVID mRNA Vaccines Get FDA Approval: Here's What To Know

The updated COVID shots from Pfizer-BioNTech and Moderna target the current KP.2 strain of SARS-CoV-2, a descendant of the highly contagious Omicron subvariant JN.1.

3 High-Yield S&P 500 Stocks to Buy and Hold

3 High-Yield S&P 500 Stocks to Buy and Hold

Three high-yield S&P 500 stocks, Devon Energy, Verizon Communications, and Pfizer Inc., are poised to provide a balanced mix of income and growth, making them attractive options for long-term investors.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

New COVID vaccines approved early

New shots from Pfizer and Moderna will be available within days. Here's how to get yours

FDA Approves Updated COVID-19 Vaccines Targeting Variants

FDA-approved updated COVID-19 vaccines crucial for protection against new strains. Get vaccinated promptly to safeguard public health.

FDA approves updated COVID-19 vaccines, shots should be available in days

Updated COVID-19 vaccines are on their way

The Independent UK

FDA greenlights updated COVID shots, prepares for fall rollout - Roll Call

The FDA approved updated COVID-19 vaccines for the 2024-25 season, preparing for an expected spike in cases this fall and winter.

inkl

Read news from The Economist, FT, and more,
with one subscription

Dividend Stocks At Risk: Is Your Income Strategy Safe?

Dividend Stocks At Risk: Is Your Income Strategy Safe?

At least three high-yield stocks have suspended their dividend payments over the last month. Here are a few other stocks whose dividends could be at risk, according to Piper Sandler's analysis.

Pfizer's Dividend Yield Surpasses 6% Mark, Attracting Investors

Pfizer's Dividend Yield Surpasses 6% Mark, Attracting Investors

Learn about the role of dividends in stock market returns and the significance of sustainable yields, using Pfizer as an example.

Pfizer CEO on moving beyond COVID vaccines to become a leader in cancer and obesity treatments

Pfizer CEO on moving beyond COVID vaccines to become a leader in cancer and obesity treatments

Pfizer's CEO Albert Bourla is trying to reposition the global pharmaceutical giant for a post-pandemic world

The Independent UK

2 Dividend Stocks to Buy in August If the Market Crash Scares You

2 Dividend Stocks to Buy in August If the Market Crash Scares You

Volatility is back on Wall Street, which is bound to scare some investors. Meanwhile, Pfizer and Starbucks are two high dividend names with limited downside which conservative investors can consider now.

CDC issues new guidelines for RSV vaccines, citing side-effect concerns

CDC issues new guidelines for RSV vaccines, citing side-effect concerns

The CDC has clarified and narrowed its recommendations for which older adults should get an RSV vaccine.

About half of US state AGs went on France trip sponsored by group with lobbyist and corporate funds

About half of US state AGs went on France trip sponsored by group with lobbyist and corporate funds

About half the U.S. state attorneys general have traveled to France for an event cosponsored by a group largely funded by companies

The Independent UK

Is Wall Street Bullish or Bearish on Pfizer Stock?

Is Wall Street Bullish or Bearish on Pfizer Stock?

Pfizer has underperformed relative to the broader market over the past year, yet Wall Street analysts remain moderately bullish about the stock’s outlook.

Get all your
news in one place.

100's of premium titles.
One news app.

Stock Market Today: Nasdaq Slumps Ahead of Microsoft Earnings

The S&P 500 also closed lower Tuesday, while the Dow Jones Industrial Average managed a win.

Pfizer Stock Slips After Beat-And-Raise Quarter: What to Know

Pfizer reported a notable year-over-year decline in Q2 earnings, but the results still beat expectations. Here's what investors should know.

S&P Futures Tick Higher Ahead of FOMC Meeting, U.S. JOLTs Report and Microsoft Earnings in Focus

September S&P 500 E-Mini futures (ESU24) are trending up +0.17% this morning as market participants braced for the start of the Federal Reserve’s two-day policy meeting while also awaiting the latest reading on U.S. job openings as well as an earnings report from tech giant Microsoft.

1 High-Yield Dividend Stock to Buy and Hold

Pfizer's stock shows signs of a potential rebound, buoyed by recent pipeline successes in hemophilia and obesity treatments, an attractive 5% dividend yield, and a rock-bottom valuation. This makes it an appealing dividend stock for value and income investors as the drug giant prepares to report earnings.

Get all your
news in one place.

100's of premium titles.
One news app.

Option Volatility And Earnings Report For July 29 – August 2

This week we have Apple, Advanced Micro Devices, Amazon, Pfizer, Coinbase, Meta Platforms, Intel, Exxon Mobil, Boeing, PayPal, Starbucks, McDonald’s and Chevron all set to report.

The Conversation

Bird flu isn’t spreading in humans for now. But there are vaccines in the pipeline if that changes

Since May, a number of poultry farms around Australia have faced outbreaks of avian influenza, or bird flu. These outbreaks have been devastating for the poultry farms affected, necessitating large-scale culls, and have caused knock-on effects for the country’s egg supplies.

Ceos Condemn Political Violence After Trump Shooting

170 major CEOs unite to denounce political violence after Trump shooting, emphasizing peace and unity.

Here's What to Expect From Pfizer’s Next Earnings Report

As Pfizer gears up to release its second-quarter earnings this month, analysts project a double-digit bottom-line dip.

1 Big Pharma Dividend Stock to Snag While It's Still Cheap

Pfizer's stock presents a compelling investment opportunity, trading at an attractive valuation with a high dividend yield, as the company makes promising progress on its oral obesity drug, danuglipron, in a market dominated by injectable treatments.

Evening Standard

Pfizer to move daily weight-loss pill to clinical trials

Firm says drug Danuglipron has shown ‘encouraging’ signs in early studies

3 Value Stocks to Buy and Hold for Passive Income

Amid market volatility, three value stocks - American International Group (AIG), Pfizer (PFE), and Schlumberger (SLB) - emerge as potential long-term investments for passive income, offering attractive valuations, solid dividends, and growth prospects for investors.

1 … 14 15 16 17

People

185,504 stories

Laxman Narasimhan

Robert Hopkins Jr

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

The Associated Press

Intel Corporation

the Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

367,603 stories

The United States

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play